ArticleNPJ precision oncology2026

Cyclin E1 overexpression identifies a therapeutically relevant poor prognostic patient subgroup in high-grade serous ovarian cancer.

Doris Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.